A detailed history of Gofen & Glossberg LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gofen & Glossberg LLC holds 528,104 shares of ABT stock, worth $60.1 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
528,104
Previous 525,580 0.48%
Holding current value
$60.1 Million
Previous $50.9 Million 14.01%
% of portfolio
1.49%
Previous 1.44%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

BUY
$95.06 - $111.52 $239,931 - $281,476
2,524 Added 0.48%
528,104 $58 Million
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $757,147 - $876,634
7,825 Added 1.51%
525,580 $50.9 Million
Q2 2022

Jul 14, 2022

BUY
$102.07 - $123.37 $530,049 - $640,660
5,193 Added 1.01%
517,755 $56.3 Million
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $436,012 - $531,688
-3,824 Reduced 0.74%
512,562 $60.7 Million
Q4 2021

Jan 25, 2022

SELL
$115.53 - $141.46 $233,370 - $285,749
-2,020 Reduced 0.39%
516,386 $72.7 Million
Q3 2021

Oct 13, 2021

SELL
$116.66 - $129.06 $173,006 - $191,395
-1,483 Reduced 0.29%
518,406 $61.2 Million
Q2 2021

Jul 13, 2021

BUY
$105.79 - $124.53 $1.07 Million - $1.26 Million
10,156 Added 1.99%
519,889 $60.3 Million
Q1 2021

Apr 13, 2021

BUY
$108.84 - $128.23 $133,220 - $156,953
1,224 Added 0.24%
509,733 $61.1 Million
Q4 2020

Jan 15, 2021

SELL
$105.0 - $114.42 $188,475 - $205,383
-1,795 Reduced 0.35%
508,509 $55.7 Million
Q3 2020

Oct 09, 2020

SELL
$91.64 - $111.29 $359,320 - $436,368
-3,921 Reduced 0.76%
510,304 $55.5 Million
Q2 2020

Jul 13, 2020

SELL
$76.57 - $98.0 $290,736 - $372,106
-3,797 Reduced 0.73%
514,225 $47 Million
Q1 2020

Apr 14, 2020

BUY
$62.82 - $91.86 $869,177 - $1.27 Million
13,836 Added 2.74%
518,022 $40.9 Million
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $702,193 - $781,705
8,944 Added 1.81%
504,186 $43.8 Million
Q3 2019

Oct 10, 2019

SELL
$81.84 - $88.74 $287,503 - $311,743
-3,513 Reduced 0.7%
495,242 $41.4 Million
Q2 2019

Jul 12, 2019

BUY
$72.88 - $85.0 $308,719 - $360,060
4,236 Added 0.86%
498,755 $41.9 Million
Q1 2019

Apr 11, 2019

BUY
$66.22 - $80.06 $626,507 - $757,447
9,461 Added 1.95%
494,519 $39.5 Million
Q4 2018

Jan 15, 2019

BUY
$65.56 - $74.27 $455,576 - $516,102
6,949 Added 1.45%
485,058 $35.1 Million
Q3 2018

Oct 11, 2018

BUY
$60.81 - $73.36 $871,103 - $1.05 Million
14,325 Added 3.09%
478,109 $35.1 Million
Q2 2018

Jul 11, 2018

SELL
$57.57 - $63.54 $7,023 - $7,751
-122 Reduced 0.03%
463,784 $28.3 Million
Q1 2018

Apr 11, 2018

BUY
$56.27 - $63.62 $12,998 - $14,696
231 Added 0.05%
463,906 $27.8 Million
Q4 2017

Jan 11, 2018

SELL
$53.68 - $57.47 $332,923 - $356,428
-6,202 Reduced 1.32%
463,675 $26.5 Million
Q3 2017

Nov 16, 2017

SELL
$48.06 - $53.64 $241,357 - $269,380
-5,022 Reduced 1.06%
469,877 $25.1 Million
Q2 2017

Aug 16, 2017

BUY
N/A
474,899
474,899 $23.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.